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ABSTRACT
Introduction: The health information needs,
information source preferences and engagement
behaviours of women with metastatic breast cancer
(mBC) depend on personal characteristics such as
education level, prior knowledge, clinical
complications, comorbidities and where they are in the
cancer journey. A thorough understanding of the
information behaviours of women living with mBC is
essential to the provision of optimal care. A preliminary
literature review suggests that there is little research on
this topic, but that there may be lessons from a slightly
broader literature. This review will identify what is
known and what is not known about the health
information needs, acquisition and influences of
women with mBC across the care continuum. Findings
will help to identify research needs and specific areas
where in-depth systematic reviews may be feasible, as
well as inform evidence-based interventions to address
the health information needs of female patients with
mBC with different demographics and characteristics
and across the mBC journey.
Methods and analysis: A scoping review will be
performed using the guidelines of Arksey and O’Malley
as updated by subsequent authors to systematically
search scientific and grey literature for articles in
English that discuss the health information needs,
source preferences, engagement styles, and associated
personal and medical attributes of women ≥18 years
living with mBC at different stages of the disease
course. A variety of databases (including Cumulative
Index to Nursing and Allied Health Literature (CINAHL),
PubMed, Excerpta Medica Database (EMBASE),
Academic Search Premier, Cochrane Database of
Systematic Reviews, PsycINFO, Health Source:
Nursing/Academic Edition, and PQDT Open), oncology,
patient advocacy and governmental websites will be
searched from inception to present day. Research and
non-research literature will be included; no study
designs will be excluded. The six-stage Arksey
and O’Malley scoping review methodological
framework involves: (1) identifying the research
question; (2) searching for relevant studies; (3)
selecting studies; (4) charting the data; (5) collating,
summarising and reporting the results; and (6)
consulting with stakeholders to inform or validate
study findings (optional). Data will be extracted and
analysed using a thematic chart and descriptive
content analysis.
Strengths and limitations of this study
▪ Systematic summarisation of the evidence will
identify information available from a wide array
of relevant sources (scientific and grey literature)
and publication types.
▪ The study will be a comprehensive review of
published papers identified via major biomedical
databases, not limited by time but covering a
period from their inception to present day.
▪ No study designs or publication types will be
excluded. As such, the review will integrate a
wide and diverse body of literature and allow the
combination of qualitative and quantitative
knowledge synthesis approaches and research
and non-research sources.
▪ The research will not be representative of the
entire metastatic breast cancer (mBC) population
as men with mBC and paediatric patients with
mBC will be excluded from the scope of the
review.
▪ The research will not specifically address the
information needs and influences of mBC subpo-
pulations, characterised by factors including age,
race, site of metastases, hormone status, timing
of advanced disease diagnosis (ie, initial vs
recurrent) and stage of metastasis, which may
be unique to each group.
▪ As a scoping review, the quality of included
studies will not be evaluated.
▪ Included studies will be limited to those pub-
lished in English due to resource constraints
represented by an inability to have articles in
other languages translated for inclusion. As
such, the results of the review will not encom-
pass the full international literature landscape on
this topic.
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Ethics and dissemination: Being a secondary analysis, this
research will not require ethics approval. Results will be
disseminated through patient support organisations and websites
and publications targeting healthcare professionals, advocates and
patients.
INTRODUCTION AND BACKGROUND
Metastatic (stage IV or stage 4) breast cancer (mBC),
otherwise called advanced or secondary breast cancer, is
a disease that has spread to distant sites of the body such
as the liver, lungs, bone, brain, and/or other tissues or
organs.1 It is an incurable but treatable disease with a
high risk of a shortened life span and continuous
cancer-related treatment to prolong progression-free sur-
vival. Breast cancer occurs primarily in women though
men can also be affected by the disease; the review will
focus on women.
Women with metastatic disease have unique character-
istics, needs, including information needs, and experi-
ences that differ from those with early stage disease.
Information and other resources provided to the broader
breast cancer community may not be appropriate to them.
Information needs of women with mBC
Several large patient surveys—the 2006 US-based Silent
Voices Survey,2 and international BRIDGE Survey
(2009),3 Count Us, Know Us, Join Us, and Here and
Now (both 2016)4—have attested to the inadequacy and
inaccessibility of mBC-speciﬁc patient information cur-
rently. Additionally, a 2013–2014 US-based mBC land-
scape analysis5 and a March 2016 international 2005–
2015 mBC Decade Report6 have reported the same con-
clusion. Gaps identiﬁed included disease state informa-
tion, prognosis, information on treatments, symptom
and side effect management, and palliation. Overall,
there appears to be an enduring and signiﬁcant unmet
need for appropriate education tailored to the informa-
tional needs of diverse mBC subgroups.7 8
Patient education or information is important to
enhance patient outcomes by empowering patients and
caregivers; optimising treatment outcomes; limiting
treatment-related adverse events; and reducing ofﬁce
visits and hospitalisations.9 It has been deﬁned as: “…
the process by which the patient comes to comprehend
his or her physical condition and self-care by the use of
various media and experiences”.10
Preliminary literature search summary
To further probe the educational needs of women with
mBC and the approaches to addressing these needs, a
preliminary review of the literature was conducted using
literature searches on PubMed and CINAHL. The
period searched was 1950 (approximate start of oral
chemotherapy) to present. This initial search was pri-
marily concerned with gaining some insights into the
character and effectiveness of teaching strategies and
methods of delivery for patient education in women
with mBC, including underserved subpopulations such
as African-American and Latina women. The role of
digital media—computer/internet-based patient educa-
tion methodologies—in optimising the education of
women with mBC was also considered.
Topics searched were: internet and patient education
and metastatic or advanced breast cancer; patient educa-
tion/patient education methods and advanced/mBC;
patient education and advanced breast cancer and
African-American/black/Latina/minority women. The
articles selected were full articles that described educa-
tional/health behavioural interventions in women with
mBC or studies of these interventions. The selection
focused on papers published in the previous 10 years. The
searches returned a total of 340 results. The titles and (in
many cases) abstracts of all 340 articles were reviewed.
The preliminary literature searches indicated that
there are very few articles on patient education and
information interventions in women with mBC in the
published literature. Nine articles discuss educational or
behavioural interventions in women with mBC (ﬁve
from the literature search and four that were not from
the search).11–19 Six further articles (four from the lit-
erature search and two that were not from the
search)20–25 provide information on the educational and
psychosocial needs of women with mBC. There are arti-
cles that address the informational needs of patients
with multiple types of cancer, but these do not necessar-
ily examine mBC on its own.
There are a few randomised controlled trials compar-
ing educational or behavioural interventions for women
with mBC. One study examined the effect of
supportive-expressive psychotherapy on the survival time
of women with mBC;19 another looked at the effective-
ness of a brief, tailored, nurse-delivered psychoeduca-
tional intervention on their quality of life or perceived
needs;12 and a third investigated the efﬁcacy of cognitive
therapy on reducing depression.16 The preliminary lit-
erature search also failed to discover any existing
scoping reviews on the subject of the proposed review.
These results suggest the need for a more comprehen-
sive and detailed examination of the literature.
Important considerations in providing patient information
Patient information-seeking and engagement may be
affected by multiple factors. Patient information engage-
ment may be affected by psychological characteristics
such as being an ‘information seeker’ or not, prefer-
ences for different information formats or learning
styles, sociodemographic characteristics such as age, eth-
nicity and educational level, clinical factors such as the
presence of comorbidities, and where a patient is on the
cancer journey.26–32
Information-seeking behaviours
Information-seeking behaviours of women with breast
cancer are highly individualistic,33 with some women
2 Tucker CA, et al. BMJ Open 2017;7:e013619. doi:10.1136/bmjopen-2016-013619
Open Access
seeking information to cope with cancer (monitors)
while others avoid information to escape the negative
feelings associated with information (blunters).34 Some
patients also prefer to receive information via a proxy or
surrogate (eg, a family member or caregiver).30 35
Information formats and learning styles
Women with mBC have also expressed varying information
source preferences and assessments. Living Beyond Breast
Cancer survey respondents cited printed patient materials,
government websites and professional medical publica-
tions as the most frequently accessed sources, but scientiﬁc
conferences and telephone education sessions were most
valued by the majority.2 Patients with cancer reactions to
content, format, sources and preferences for the timing
and delivery mechanisms of information will impact their
information behaviours.36 For example, readability, com-
prehensibility and cultural relevance may inﬂuence
patient engagement with health information.36 37
Age
Generational differences affect information needs,
source preferences, engagement behaviours and prefer-
ences. Older women with cancer may prefer more
passive roles and express less need for informa-
tion.6 32 38 39 Many younger women with breast cancer
may experience treatment-related sexual dysfunction
that may not completely resolve40 so information on
sexuality may be of special interest.41
Education and health literacy
Inadequate health literacy (the degree to which indivi-
duals have the capacity to obtain, process and under-
stand basic health information and services needed to
make appropriate health decisions)42 poses barriers to
patients with cancer understanding of their disease and
treatment options.43 Moreover, higher educational level
has been found to be associated with a more active
information-seeking style.28 32 44 45
Ethnicity
Ethnicity, race and cultural background also inﬂuence
patients with cancer information-seeking behaviours.6 46 47
Thus, the use of family-based and community-based (vs
purely individually directed), religious and spiritual
coping strategies by African-American and Latina women
with breast cancer may inﬂuence the way they access
health information.6 46 48
Position on the care continuum
As with other cancers,32 the information needs, includ-
ing the type of information sought, of women with mBC
vary with the stage of the patient pathway (ie, mBC diag-
nosis, treatment, including long-term survivorship, and
the post-treatment, end-of-life phase).5 An important
aspect of cancer care is provision of speciﬁc information
that is tailored to the speciﬁc stage of the patient along
the disease continuum.29 49
Around the time of diagnosis, patients want informa-
tion about the disease, side effect management, preven-
tion of treatment-related side effects and
prognosis;15 21 25 at the time of treatment, treatment
information (ie, monitoring treatment-related side
effects and the risk-beneﬁt proﬁle of novel treatments)
may be most relevant.50 Long-term survivors’ informa-
tional needs relate to their diagnosis, prognosis and
treatment options, including understanding and man-
aging treatment-related toxicities and effects such as psy-
chosocial complications (eg, anxiety and depression and
social complications).6 14 In the end-of-life and palliative
treatment phase, speciﬁc information needs include late-
disease risks, complications of advanced disease, speciﬁc
palliative care therapies and potential side effects, pain
management, and skin care.51
Study rationale
The rationale for the proposed research is that provision
of quality care to women with mBC requires information
provision appropriate to different time points in the
care continuum.14 15 21 25 50 51 This scoping review aims
to synthesise current knowledge on female patients with
mBC information needs, source preferences and
engagement behaviours, and inﬂuences as these evolve
across their cancer journey.
Study objectives
The aim of this study is to explore the question: What
information exists in the literature about the informa-
tion needs, source preferences, engagement behaviours
and associated sociodemographic and situational factors
(such as disease-related or treatment-related factors) of
women ≥18 years with mBC at different time points of
the cancer care continuum?
Anticipated utility of the review
The feasibility of in-depth, systematic reviews will be
determined by the scoping review.
Findings will also help to identify research needs and
inform evidence-based interventions to address the
health information needs of female patients with mBC
with different demographics and characteristics and
across the mBC journey.
Methods and analysis
A scoping review will be conducted of the scientiﬁc, clin-
ical and broader literature for articles in English addres-
sing female patients with mBC information needs,
source preferences, usage and related factors across the
mBC disease course. Because of a lack of resources for
translation, articles published in languages other than
English will be excluded.
While recognising the existence of several varying deﬁ-
nitions of this methodology, for purposes of this review,
by scoping review or study is meant: “…a form of knowl-
edge synthesis that addresses an exploratory research
question aimed at mapping key concepts, types of
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evidence, and gaps in research related to a deﬁned area
or ﬁeld by systematically [and iteratively] (insertion by
O’Brien et al52) searching, selecting, and synthesizing
existing knowledge”.53
In their foundational article on scoping review meth-
odology, Arksey and O’Malley54 identiﬁed possible aims
of scoping reviews as: to examine the extent, range and
nature of research activity, determine the value of under-
taking a full systematic review, summarise and dissemin-
ate research ﬁndings, or identify gaps in the existing
literature. Initially, at least the ﬁrst two aims will be
addressed via this scoping review; potentially all four
may be fulﬁlled.
Arksey and O’Malley54 also proposed a six-stage meth-
odological framework: (1) identifying the research ques-
tion; (2) searching for relevant studies; (3) selecting
studies; (4) charting the data; (5) collating, summarising
and reporting the results; and (6) consulting with stake-
holders to inform or validate study ﬁndings (optional).
Both Levac et al55 and Daudt et al56 have made signiﬁ-
cant updates to the Arksey and O’Malley scoping review
framework. This study protocol is informed by and
incorporates enhancements and reﬁnements made by
these two groups.
The primary objective is to provide a critical review of
the state of the research apparent from the literature
about the information needs and behaviours of women
with mBC as they evolve across the disease course,
including identifying gaps insofar as possible.
To ensure comprehensiveness of the research, infor-
mation is deﬁned broadly as comprising both cancer-
related and non-cancer-related information, namely, psy-
chological, medical and social information.
Literature review search strategy
The scoping review will consider the international
English language literature (both peer-reviewed and
‘grey’) that discusses patient information needs, sources
and acquisition, including associated variables of women
aged ≥18 with advanced or metastatic stage IV4 breast
cancer. Primary research studies, systematic reviews,
meta-analyses, clinical guidelines, meeting abstracts and
dissertations, interviews, text and opinion literature, and
other publication types will be included. In order to
capture a diverse body of evidence, encompassing quan-
titative, qualitative and mixed-methods approaches, and
in keeping with the scoping review methodology focus
on summarising breadth of evidence, no study designs
will be excluded.
As described in the Joanna Briggs Institute Reviewers’
Manual 2015, a three-step search strategy will be used in
this research:57
1. An initial limited search of PubMed and CINAHL fol-
lowed by analysis of the text words contained in the
title and abstract of the retrieved articles.
2. A second search using all identiﬁed keywords and
index terms across all proposed databases.
3. A search of the reference list of all identiﬁed reports
and articles for additional studies.
The proposed databases to be searched (from incep-
tion to present day) include CINAHL, PubMed,
EMBASE, Academic Search Premier, Cochrane Database
of Systematic Reviews, PsycINFO, Health Source:
Nursing/Academic Edition, Epistemonikos, the Joanna
Briggs Institute Database of Systematic Reviews and
Implementation Reports ( JBISRIR), the Evidence for
Policy and Practice Information and Co-ordinating
Centre (EPPI-Centre) and Education Resources
Information Center (ERIC).
Patient advocacy websites and publications and cancer
websites will be investigated for unpublished studies.
The search for unpublished studies will also include the
following websites: PQDT Open (http://pqdtopen.
proquest.com/search.html, which provides open access
to dissertations and theses); Google Scholar; WHO,
http://www.who.int; Clinical Trials.gov; Institute of
Medicine (IOM), http://www.iom.edu; the National
Cancer Institute (NCI), http://www.cancer.gov; National
Institutes of Health (NIH), http://www.nih.gov; Agency
for Healthcare Research and Quality (AHRQ), http://
www.ahrq.gov; New York Academy of Medicine, http://
www.nyam.org/; and the Virginia Henderson Global
Nursing e-Repository of the Honor Society of Nursing,
Sigma Theta Tau International, http://www.
nursinglibrary.org, a repository dedicated to sharing
nursing publications.
The search for grey literature will include searches of
Open-Grey (http://www.opengrey.edu), an open access
database of European grey literature and the Grey
Literature Report (http://www.greylit.org), a publication of
the New York Academy of Medicine.
Relevant oncology websites will be searched, including
the American Society of Clinical Oncology (ASCO),
http://www.asco.org; Oncology Nursing Society (ONS),
http://www.ons.org; European Society for Medical
Oncology (ESMO), http://www.esmo.org; and the
American Cancer Society (ACS), http://www.acs.org
websites.
The initial search will consist of each of the following
terms linked by OR: information-seeking, information
needs, information acquisition, information resources,
information sources, information source preferences,
information support, information dissemination
methods, health information, patient education, health
education, patient education methods, therapeutic
patient education, patient knowledge, treatment educa-
tion, patient concerns, patient satisfaction, patient com-
munication, patient information, patient experience,
clinical communication, physician-patient communica-
tion, patient-provider communication, communication
challenges and patient-cent(e)red communication AND
each of the following terms linked by OR: advanced
breast cancer, metastatic breast cancer, secondary breast
cancer, stage IV breast cancer and stage 4 breast cancer.
A ﬂexible and iterative approach will be employed
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enabling redeﬁning and/or ﬁne tuning of this initial
search strategy based on the results obtained.52
To assess the completeness of the above search, hand
searching of reference lists and bibliographies of
included studies and two or three appropriate journals
for the preceding 6 months to a year will be conducted.
Proposed journals are the Journal of Cancer Education,
Patient Education and Counseling, and Support Care Cancer.
Endnote will be used to manage the references
retrieved.
Study selection
The review will exclude articles that:
4. Include patients ≤18 years old. As with other paedi-
atric patients with cancer, paediatric patients with
mBC are likely to have unique information and
support needs that cannot be adequately addressed
within the framework of this review, but will require
a separate speciﬁc review.
5. Focus mainly on men or do not differentiate
between the needs of male and female patients with
mBC. Although many of the ﬁndings concerning
information needs, sources and engagement may be
transferable from women to men, we consider that
men with mBC have special needs worthy of a separ-
ate review. This protocol and scoping review will
focus only on women with mBC.
6. Solely report economic research (ie, cost-
effectiveness or cost-utility studies).
7. Relate to prevention and screening for breast
cancer.
8. Describe genetics unless they discuss information
needed by or provided to women with mBC.
9. Focus on the information needs and behaviours of
women with early stage or primary breast cancer.
10. Focus exclusively on the information needs and
engagement of patients’ partners or family
members. However, articles containing information
relative to the inﬂuence of patient/caregiver inter-
actions on the patient information engagement
behaviours of women with mBC will be included.
11. Include other types of cancer in addition to mBC,
but which do not discuss the information needs,
sources and behaviours of women with mBC separ-
ately from those of patients with other types of
cancer.
12. Focus on the informational or educational needs
of healthcare professionals, unless they also
address the information needs of women with
mBC.
13. Concern cancer risk, mortality and epidemiology.
Articles for inclusion will be selected using a three-step
process: (1) titles of articles will be scanned to deter-
mine eligibility based on the inclusion and exclusion cri-
teria; (2) article titles and abstracts will be reviewed
using the eligibility criteria; (3) full-text versions of all
potentially relevant articles will be retrieved for inclusion
consideration.
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As recommended in the Levac et al55 methodological
update, this stage of the review will be approached as an
iterative process comprising searching the literature,
reﬁning the search strategy and reviewing articles for
study inclusion.
Given the patient-centred focus of the proposed
research, it is likely that qualitative evidence will be an
important element of the output of this study. It has
been expressed as both a strength and a limitation of
scoping reviews that at best they encompass a wide array
of literature and research study designs though the
diverse and potentially complex character of the data
obtained may make analysis and synthesis very demand-
ing.52 Despite the contrasting methodologies of quanti-
tative and qualitative research, the proposed review will
iteratively address these issues as the literature review
evolves, data are generated, and a clearer understanding
of the scope and character of the mBC information
behaviour literature develops. Qualitative data will be
addressed using qualitative methodology: an interpretive
approach to understanding patients with mBC percep-
tions, values, beliefs and experiences relative to informa-
tion needs, seeking, quality and knowledge assimilation
may be an applicable approach to an analysis and syn-
thesis of qualitative literature results.58 59
Data abstraction
This step in the review process relates to ‘charting the
results’ in review terminology. Given the iterative nature
of scoping reviews, the exact path and methodology of
data abstraction may change depending on the data
obtained. The proposals outlined here are preliminary
and subject to modiﬁcation as the review evolves.
The systematic review typology chart developed by
Rutten et al32 and modiﬁed by van Mossel et al49 will be
adapted to create a preliminary table (table 1) to record
authors and dates of included articles and types of infor-
mation needs and sources mentioned using the broad
categories they proposed. Relevant subcategories of infor-
mation speciﬁc to breast cancer and/or mBC will be for-
mulated using the search results; these will be used to
generate two tables recording the types of information
needs and sources mentioned in reviewed articles.
The methodological quality of individual included
studies will not be assessed since the aim of a scoping
study is to conduct a comprehensive search enabling the
identiﬁcation of gaps in the evidence base and indica-
tion of subject areas for future reviews.49 60 While Daudt
et al56 strongly recommend incorporation of this compo-
nent into the scoping review exercise, there does not
appear to be currently sufﬁcient guidance contained
within the scoping review literature to assist in conduct-
ing this process. This consideration is especially pertin-
ent as the evaluative task involves assimilation of
evidence drawn from a diverse body of qualitative, quan-
titative, research and non-research and other literature
that is not necessarily amenable to the usual methods of
quality assessment.61
As recommended by Levac et al,55 charting will be an
iterative step; data will be continually extracted and the
charting form updated accordingly. Additionally, the
charting form will be piloted using the ﬁrst 5–10 studies
and reviewed jointly by the authors to assess whether it
meets the needs of the research question and the
purpose of this review, with reﬁnements made before
embarking on the full scale charting exercise.55 56
Also, as observed by O’Brien et al,52 since the process of
charting, collating and summarising of included publica-
tions will be iterative, knowledge synthesis may involve a
descriptive component (presenting frequencies of litera-
ture characteristics) as well as an analytical aspect, that is,
synthesis of qualitative and quantitative data with the-
matic or content analysis for relevant variables.
RESULTS
Data abstraction and synthesis will use both tabular and
textual (descriptive) approaches, which will provide
adequate ﬂexibility to accommodate both quantitative
and qualitative literature.
This stage of the scoping review exercise falls under
the collating, summarising and reporting the results
stage of the Arksey and O’Malley framework.54 As sug-
gested by Levac et al,55 this stage may be segmented into
three discrete steps: analysing the data (including
descriptive numerical summary analysis and qualitative
thematic analysis); reporting the results linked to the
research question; and interpreting the implications of
the results for research, policy and practice.
Characteristics of the literature included in the review
will be summarised in a table (table 2), and the stages of
the cancer care continuum in the reviewed articles will
also be tabulated (table 3). A descriptive (narrative)
summary of the articles included in the review, describ-
ing the aims or purposes of included articles, concepts
or approaches used in each, and the results that relate
to the review question, will be presented. As suggested
by Levac et al,55 a thematic analysis akin to a qualitative
data analysis approach may be attempted intended to
organise the data into overarching themes. The ﬁndings
might be presented using tables and descriptions
aligned with identiﬁed themes.56
Any potential implications for evidence-based patient
education practice and knowledge gaps meriting primary
research and/or systematic reviews will be presented.57
Stakeholder consultation
The second part of the study will involve primary research
and entails interaction with patients with mBC to solicit
their contributions on their cancer-related information
needs and information engagement across the disease
course. Ethics approval for this phase of the study will be
sought from the Education Research Ethics Sub-Committee
of the Faculty of Arts FREC of Plymouth University.
The methodology will be two-pronged: (1) monitoring
of online sources, including social networking sites,
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discussion boards and online support groups for relevant
postings, including tweets and chats. These inputs will be
synthesised using qualitative thematic analysis/discourse
or conversation analysis. In-person engagement with
patients with mBC support groups around the same ques-
tions will provide additional data on the research topics
and context to the scoping review ﬁndings. (2) A survey
of patients with mBC (using an online method as well as
hard copy questionnaires) will be conducted to test the
ﬁndings from the online monitoring exercise. This
corresponds to the sixth stage of the Arksey and O’Malley
framework: stakeholder consultation.
Ethics and dissemination
All data in this review will be gathered through searches
of literature and other online databases, and no per-
sonal health information will be collected; thus, ethics
committee approval will not be required for the scoping
review portion.
Research ﬁndings will be published and presented to
patients and their families and caregivers through patient
support and advocacy websites and organisations.
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